Phase II Placebo-controlled Trial of Lisinopril and Coreg CR to Reduce Cardiotoxicity in Patients With Breast Cancer Receiving (Neo)Adjuvant Chemotherapy With Trastuzumab (Herceptin)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2015
At a glance
- Drugs Carvedilol (Primary) ; Lisinopril (Primary)
- Indications Heart disorders
- Focus Therapeutic Use
- 08 Jul 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Jul 2017 as reported by ClinicalTrials.gov record.
- 08 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 20 May 2013 Planned End Date changed from 1 Mar 2013 to 1 Mar 2016 as reported by ClinicalTrials.gov.